 | |||||
| lose weight | |||||
| NEWS | |||||
| Will Ozempic Kill Donut Sales? Krispy Kreme Stock Downgraded As Weight Loss Drugs Boom. Topline. Truist cut its outlook Monday for shares of doughnut chain Krispy Kreme, citing the potential impact of weight loss and diabetes drugs like ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
